LADENBURG THALMANN FINANCIAL SERVICES INC. - INOVIO PHARMACEUTICALS INC ownership

INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 117 filers reported holding INOVIO PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 1.02 and the average weighting 0.0%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of INOVIO PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$23,000
+64.3%
7,082
+2.9%
0.00%
Q3 2019$14,000
-33.3%
6,8820.0%0.00%
Q2 2019$21,000
-16.0%
6,8820.0%0.00%
Q1 2019$25,000
-21.9%
6,882
-6.5%
0.00%
Q4 2018$32,000
-33.3%
7,357
-14.5%
0.00%
Q3 2018$48,000
-79.7%
8,607
-82.9%
0.00%
-100.0%
Q2 2018$237,0000.0%50,4570.0%0.00%0.0%
Q1 2018$237,000
+13.9%
50,457
+0.3%
0.00%0.0%
Q4 2017$208,000
-36.4%
50,320
-2.4%
0.00%
-50.0%
Q3 2017$327,000
-15.9%
51,561
+3.8%
0.00%
-20.0%
Q2 2017$389,000
+23.9%
49,674
+4.9%
0.01%
+25.0%
Q1 2017$314,000
+423.3%
47,349
+521.6%
0.00%
+300.0%
Q4 2016$60,000
-10.4%
7,617
+7.4%
0.00%0.0%
Q3 2016$67,000
+11.7%
7,092
+8.3%
0.00%0.0%
Q2 2016$60,000
+3.4%
6,548
-3.0%
0.00%0.0%
Q1 2016$58,000
+81.2%
6,748
+44.3%
0.00%0.0%
Q4 2015$32,000
+39.1%
4,675
+19.1%
0.00%
Q3 2015$23,000
-23.3%
3,925
+5.4%
0.00%
-100.0%
Q2 2015$30,000
+114.3%
3,725
+115.9%
0.00%
Q1 2015$14,000
+7.7%
1,725
+21.1%
0.00%
Q4 2014$13,000
-7.1%
1,4250.0%0.00%
Q3 2014$14,000
-26.3%
1,425
-20.8%
0.00%
-100.0%
Q2 2014$19,0001,8000.00%
Other shareholders
INOVIO PHARMACEUTICALS INC shareholders Q1 2016
NameSharesValueWeighting ↓
Defender Capital, LLC. 648,800$1,920,0001.55%
Round Table Services, LLC 339,391$998,0000.31%
ARK Investment Management 3,955,017$11,628,0000.29%
Nikko Asset Management Americas, Inc. 4,884,100$14,359,0000.28%
WASATCH ADVISORS LP 6,735,726$19,803,0000.19%
Cedar Brook Financial Partners, LLC 41,500$122,0000.06%
Unified Trust Company, N.A. 15,716$46,0000.03%
Bay Colony Advisory Group, Inc d/b/a Bay Colony Advisors 13,500$40,0000.03%
STONERIDGE INVESTMENT PARTNERS LLC 16,914$50,0000.02%
Sumitomo Mitsui Trust Holdings, Inc. 4,884,100$14,359,0000.01%
View complete list of INOVIO PHARMACEUTICALS INC shareholders